CTLA4Ig alone or in combination with low-dose cyclosporine fails to reverse acute rejection of renal allograft in the rat

Transplantation

Volumn 61, Issue 9, 1996, Pages 1320-1322

  Perico, Norberto ^a,b   Amuchastegui, Susanna ^a   Bontempelli, Mario ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE CLEARANCE; GRAFT REJECTION; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY GRAFT; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CYCLOSPORINE; GRAFT REJECTION; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; RECOMBINANT FUSION PROTEINS;

EID: 0029937962     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199605150-00006     Document Type: Article

References (19)

1. Colvin RB. Cellular and molecular mechanisms of allograft rejection. Annu Rev Med 1990; 41: 361.
2. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen. Role of peptides. Transplantation 1994; 57: 1295.
3. Lafferty KJ, Andrus L, Prowse SJ. Role of lymphokine and antigen in the control of specific T cell responses. Immunol Rev 1980; 51: 279.
4. Steinman RM, Young JW. Signals arising from antigen-presenting cells. Curr Opin Immunol 1991; 3: 361.
5. Schwartz RH. Acquisition of immunologie self-tolerance. Cell 1989; 57: 1073.
6. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349.
7. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990; 11: 211.
8. Ledbetter JA, Imboden JB, Schieven GL, et al. CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood 1990; 75: 1531.
9. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321.
10. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991; 174: 561.
11. Brunet JF, Venizot F, Luciani MF, et al. A new member of the immunoglobulin superfamily CTLA-4. Nature 1987; 328: 267.
12. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts by CTLA4Ig. Science 1992; 257: 789.
13. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
14. Lin H, Bolling SF, Linsley PS. Long-term acceptance of major histocompatibility complex mismatched cardiac allograft induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
15. Perico N, Imberti O, Bontempelli M, Remuzzi G. Toward novel antirejection strategies: in vivo immunosuppressive properties of CTLA4Ig. Kidney Int 1995; 47: 241.
16. Sayegh MH, Akalin E, Hancock WW, Russel ME, Carpenter CB, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 191: 1869.
17. Rossini M, Belloni A, Remuzzi G, Perico N. Thromboxane receptor blockade attenuates the toxic effect of cyclosporine in experimental renal transplantation. Circulation 1990; 81 (suppl 1): 61.
18. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc Natl Acad Sci USA 1992; 89: 7762.
19. Sayegh MH, Turka LA. T cell costimulatory pathways: promising novel target for immunosuppression and tolerance induction. J Am Soc Nephrol 1995; 6: 1143.